Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 8,684 | 10,098 | 10,407 | 10,520 | 12,696 |
| Operating Income | -8,684 | -10,098 | -10,407 | -10,520 | -12,696 |
| Interest Expense | 1,188 | 1,175 | 1,175 | 1,069 | 995 |
| Other Income | 675 | 669 | 684 | 739 | 751 |
| Pre-tax Income | -9,197 | -10,604 | -10,898 | -10,849 | -12,941 |
| Income Tax | -869 | N/A | 0 | N/A | -1,406 |
| Net Income Continuous | -8,328 | -10,604 | -10,898 | -10,849 | -11,535 |
| Net Income | $-8,328 | $-10,604 | $-10,898 | $-10,849 | $-11,535 |
| EPS Basic Total Ops | -0.23 | -0.30 | -0.35 | -0.35 | -0.37 |
| EPS Basic Continuous Ops | -0.23 | -0.30 | -0.34 | -0.35 | -0.37 |
| EPS Diluted Total Ops | -0.23 | -0.30 | -0.35 | -0.35 | -0.37 |
| EPS Diluted Continuous Ops | -0.23 | -0.30 | -0.34 | -0.35 | -0.37 |
| EPS Diluted Before Non-Recurring Items | -0.23 | -0.30 | -0.34 | N/A | N/A |
| EBITDA(a) | $-8,385 | $-9,813 | $-10,133 | $-10,347 | $-12,570 |